PT  - JOURNAL ARTICLE
ED  - ,
TI  - Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn’s disease
AID  - 10.1136/ebm.13.4.115
DP  - 2008 Aug 01
TA  - Evidence Based Medicine
PG  - 115--115
VI  - 13
IP  - 4
4099  - http://ebm.bmj.com/content/13/4/115.short
4100  - http://ebm.bmj.com/content/13/4/115.full
SO  - Evid Based Med2008 Aug 01; 13